Tower Research Capital LLC (Trc) Pasithea Therapeutics Corp. Transaction History

Tower Research Capital LLC (Trc)

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	SELL	$0.28 - $0.48 $26 - $45	-94 Reduced 0.75%	12,396 $4,000
Q3 2023 Nov 14, 2023	BUY	$0.44 - $0.63 $0 - $0	1 Added 0.01%	12,490 $5,000
Q2 2023 Aug 14, 2023	SELL	$0.31 - $0.5 $34 - $56	-112 Reduced 0.89%	12,489 $6,000
Q1 2023 May 09, 2023	SELL	$0.38 - $0.73 $930 - $1,787	-2,448 Reduced 16.27%	12,601 $5,000
Q4 2022 Feb 10, 2023	BUY	$0.55 - $26.0 $5,164 - $244,140	9,390 Added 165.93%	15,049 $10,000
Q3 2022 Nov 10, 2022	BUY	$0.08 - $26.4 $272 - $89,892	3,405 Added 151.06%	5,659 $7,000
Q2 2022 Aug 15, 2022	BUY	$16.52 - $27.0 $37,236 - $60,858	2,254 New	2,254 $2,000
Q1 2022 May 12, 2022	SELL	$19.4 - $35.8 $570,069 - $1.05 Million	-29,385 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$28.8 - $112.0 $793,468 - $3.09 Million	27,551 Added 1502.24%	29,385 $52,000
Q3 2021 Nov 15, 2021	BUY	$54.8 - $71.2 $100,503 - $130,580	1,834 New	1,834 $6,000

Ticker KTTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,398,700
Market Cap $79.1M
Description
Pasithea Therapeutics Corp., a biotechnology company, engages in research and discovery of treatments for psychiatric and neurological disorders. It also intends to operate anti-depression clinics and provide business support services using trained pharmacists to administer intravenous infusions of ketamine. The company was incorporated in 2020 ...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.